ANVISA = EMA’s ABEL! [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2016-05-19 18:23 (3193 d 17:54 ago) – Posting: # 16335
Views: 11,448

Hi earlybird,

that’s a fine piece of cake! We have to change the code of the next release of PowerTOST.
@Detlew: Only ANOVA also in Section 1.j) of the current RESOLUÇÃO – RE Nº 1.170, DE 19 DE ABRIL DE 2006

❝ The correct study design for this case is the full replicate design, i.e. a 4-period design.


The WHO’s Working Document does not specify which replicate designs are acceptable (contrary to the EMA mentioning 3- and 4-period replicates). IMHO, the 4-period replicate is the best design anyway…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
111 visitors (0 registered, 111 guests [including 13 identified bots]).
Forum time: 11:18 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5